SCHEMBL21844847

SCHEMBL21844847

CN(CCCO)CCc1cccc(C(=O)Nc2cccc(Cl)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TMEM97 Q5BJF2 2/20 0.52
▸ SIGMAR1 Q99720 2/20 0.52
▸ NPC1 O15118 4/20 0.51
▸ RAB9A P51151 4/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ KCNK3 O14649 2/20 0.49
▸ KCNK9 Q9NPC2 2/20 0.49
▸ LMNA P02545 1/20 0.47
▸ PTBP1 P26599 1/20 0.47
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21844897 0.89 NPC1 (0.51) TMEM97SIGMAR1NPC1RAB9ASMN1; SMN2
SCHEMBL21844826 0.83 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL21844862 0.81 MEN1 (0.59) RAB9ASMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL20083997 0.80 NPC1 (0.53) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL15276915 0.77 LMNA (0.60) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL20083991 0.74 GRM4 (0.46) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL3675463 0.74 KCNK3 (0.84) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL21844896 0.74 PARP1 (0.49) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL2065025 0.73 CYP3A4 (0.44) CA1
SCHEMBL30802691 0.73 KCNK3 (0.68) NPC1RAB9AMEN1KMT2AKCNK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
Send feedback